A first-in-human dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of oral 2-hydroxyoleic acid (2-OHOA) in adult patients (pt) with advanced solid tumors including grade III/IV glioblastoma multiforme (GBM).

Roda, D; Drew, Y; Azaro, A; Smith, AD; Greystoke, A; Sicart, E; Escriba, PV; Busquets, X; Llado, V; Tur, V; Klumper, E; Ahnert, JR; Molife, LR; Plummer, R

A first-in-human dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of oral 2-hydroxyoleic acid (2-OHOA) in adult patients (pt) with advanced solid tumors including grade III/IV glioblastoma multiforme (GBM).

Lookup NU author(s): Dr Yvette Drew ORCiD, Professor Alastair Greystoke ORCiD, Professor Ruth Plummer

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Roda D, Drew Y, Azaro A, Smith AD, Greystoke A, Sicart E, Escriba PV, Busquets X, Llado V, Tur V, Klumper E, Ahnert JR, Molife LR, Plummer R

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 2015 American Society of Clinical Oncology Annual Meeting

Year of Conference: 2015

Print publication date: 18/05/2015

Acceptance date: 01/01/1900

ISSN: 0732-183X

Publisher: American Society of Clinical Oncology

URL: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/2513?sid=cdb2629b-4743-4672-baf3-83efb465f3e2

Series Title: Journal of Clinical Oncology

ePrints

A first-in-human dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of oral 2-hydroxyoleic acid (2-OHOA) in adult patients (pt) with advanced solid tumors including grade III/IV glioblastoma multiforme (GBM).

Downloads

Publication metadata

Share